Method for quantitative determination of PSMA key intermediate chiral isomer
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SUZHOU IBIO TECH CO LTD
- Publication Date
- 2021-09-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of chemistry and medicine, and in particular relates to a method for quantitatively determining the chiral isomer of a key intermediate of PSMA. Background technique
[0002] Prostate-specific membrane antigen (PSMA) is a type II cell surface membrane-bound glycoprotein with a molecular weight of about 110kD, including an intracellular fragment (amino acid sequence 1-18), a transmembrane domain (amino acid sequence 19-43), and an extracellular domain (amino acid sequence 44-750). The intracellular fragment and the transmembrane domain are now considered to have no significant role, while the extracellular domain is involved in a variety of specific activities. PSMA plays a very important role in the nervous system, it promotes the metabolism of N-acetylaspartamine (NAAG) and generates glutamic acid and N-acetylaspartic acid. Correspondingly, it is also sometimes related to N-acetyl α-linked acid dipeptidas...